Crohn’s & Colitis Australia launch #LIVEFEARLESS campaign
April 26, 2017 5:41 pmOver five million people live with Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD) worldwide. 75,000…>Read More
Over five million people live with Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD) worldwide. 75,000…>Read More
Crohn’s & Colitis Australia are delighted to extend an invitation to you to attend our Annual General Meeting followed…>Read More
A ground breaking Australian study, supported by Gandel Philanthropy through Crohn’s & Colitis Australia (CCA), took out top honours at…>Read More
On 1 April 2014, Remicade® (infliximab) was made available on the Pharmaceutical Benefits Scheme (PBS) in limited circumstances for patients…>Read More
A new online tool that aims to radically improve cancer prevention in patients with inflammatory bowel disease (IBD) was launched…>Read More
13 December, 2013 CCA is delighted to welcome an historic $500,000 matched funding agreement granted by the Federal Government that…>Read More
Crohn’s & Colitis Australia has been awarded a Victorian Government Health Condition support grant, enabling us to extend our support…>Read More